ID   MDA-IBC-3
AC   CVCL_HC47
SY   MDA-IBC3; MDAIBC3; MD Anderson-Inflammatory Breast Cancer-3
DR   ArrayExpress; E-MTAB-11134
DR   GEO; GSM1008922
DR   GEO; GSM1215265
DR   GEO; GSM3145722
DR   Wikidata; Q54904575
RX   DOI=10.4172/2161-0681.1000119;
RX   PubMed=20808935;
RX   PubMed=23784380;
RX   PubMed=24162158;
RX   PubMed=35042871;
CC   Characteristics: ER-negative, PR-negative and ERBB2-positive.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=20808935
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   TH01: 8
ST   TPOX: 10,11
ST   vWA: 18,19
DI   NCIt; C4001; Breast inflammatory carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
RX   DOI=10.4172/2161-0681.1000119;
RA   Robertson F.M., Chu K., Fernandez S.V., Mu Z.-M., Zhang X.-J., Liu H.,
RA   Boley K.M., Alpaugh R.K., Ye Z.-M., Wright M.C., Luo A.Z., Oraes R.,
RA   Wu H., Zook M.B., Barsky S.H., Krishnamurthy S., Cristofanilli M.;
RT   "Genomic profiling of pre-clinical models of inflammatory breast cancer
RT   identifies a signature of epithelial plasticity and suppression of
RT   TGFbeta signaling.";
RL   J. Clin. Exp. Pathol. 2:119.1-119.11(2012).
//
RX   PubMed=20808935; DOI=10.1371/journal.pone.0012180; PMCID=PMC2922340;
RA   Klopp A.H., Lacerda L., Gupta A., Debeb B.G., Solley T., Li L.,
RA   Spaeth E., Xu W., Zhang X.-M., Lewis M.T., Reuben J.M., Krishnamurthy S.,
RA   Ferrari M., Gaspar R., Buchholz T.A., Cristofanilli M., Marini F.C.,
RA   Andreeff M., Woodward W.A.;
RT   "Mesenchymal stem cells promote mammosphere formation and decrease
RT   E-cadherin in normal and malignant breast cells.";
RL   PLoS ONE 5:E12180-E12180(2010).
//
RX   PubMed=23784380; DOI=10.1007/s10549-013-2600-4; PMCID=PMC4273486;
RA   Fernandez S.V., Robertson F.M., Pei J.-M., Aburto-Chumpitaz L.D.,
RA   Mu Z.-M., Chu K., Alpaugh R.K., Huang Y., Cao Y., Ye Z.-M., Cai K.Q.,
RA   Boley K.M., Klein-Szanto A.J.P., Devarajan K., Addya S.,
RA   Cristofanilli M.;
RT   "Inflammatory breast cancer (IBC): clues for targeted therapies.";
RL   Breast Cancer Res. Treat. 140:23-33(2013).
//
RX   PubMed=24162158; DOI=10.1007/s10549-013-2743-3; PMCID=PMC3832776;
RA   Prat A., Karginova O., Parker J.S., Fan C., He X.-P., Bixby L.M.,
RA   Harrell J.C., Roman E., Adamo B., Troester M.A., Perou C.M.;
RT   "Characterization of cell lines derived from breast cancers and normal
RT   mammary tissues for the study of the intrinsic molecular subtypes.";
RL   Breast Cancer Res. Treat. 142:237-255(2013).
//
RX   PubMed=35042871; DOI=10.1038/s41523-021-00379-6; PMCID=PMC8766434;
RA   Rypens C., Bertucci F., Finetti P., Robertson F.M., Fernandez S.V.,
RA   Ueno N.T., Woodward W.A., Van Golen K., Vermeulen P., Dirix L.,
RA   Viens P., Birnbaum D., Devi G.R., Cristofanilli M., Van Laere S.;
RT   "Comparative transcriptional analyses of preclinical models and
RT   patient samples reveal MYC and RELA driven expression patterns that
RT   define the molecular landscape of IBC.";
RL   NPJ Breast Cancer 8:12.1-12.12(2022).
//